DW Healthcare Partners Invests in Bio Agri Mix

CarePartners Pharmacy Acquires National Drug Wholesale (NDW)

November 17, 2025

Pharmaceuticals

CarePartners Pharmacy, a national specialty infusion pharmacy based in Libertyville, Illinois, has acquired National Drug Wholesale (NDW), a Santa Clara, California–based pharmaceutical wholesaler and distributor. The deal expands CarePartners’ specialty distribution capabilities, strengthens its biosimilar supply chain and licensing footprint, and supports its payer- and manufacturer-focused cost-containment programs.

Phibro Acquires Zoetis' Medicated Feed Additive Business

November 1, 2024

Veterinary

Phibro Animal Health Corp. has completed the acquisition of Zoetis Inc.'s medicated feed additive product portfolio and certain water‑soluble products. The deal transfers more than 37 product lines, six manufacturing sites (U.S., Italy, China) and a team of over 300 employees to Phibro, expanding its species coverage and product capabilities across cattle, swine and poultry.

Health & Wellness Partners Acquires Hybrid Healthcare Communications

October 6, 2023

Healthcare Services

Health & Wellness Partners (HWP), a PE-backed medical and scientific communications agency, has acquired Hybrid Healthcare Communications to combine HWP's medical content and strategic offerings with Hybrid's digital and interactive engagement capabilities. The deal expands HWP's service capabilities across medical affairs, marketing, and speaker bureau offerings and strengthens its digital and virtual engagement solutions.

Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners

August 30, 2022

Veterinary

Dechra Pharmaceuticals PLC has completed the acquisition of Med-Pharmex Holdings, Inc. from DW Healthcare Partners. The deal brings a US-based, fully integrated veterinary pharmaceutical manufacturer (Med-Pharmex) into Dechra's global animal-health platform to strengthen its manufacturing capabilities and North American footprint.

DW Healthcare Partners Invests in Vets Plus and Noble Pharma

January 10, 2022

Veterinary

DW Healthcare Partners completed a growth capital investment in Vets Plus, Inc. and Noble Pharma, LLC, backing the animal-health manufacturer to scale operations and expand pharmaceutical capabilities. As part of the transaction, Dave Nelson becomes President and CEO of Vets Plus while founder Raj Lall transitions from day-to-day management and remains on the board.

DW Healthcare Partners Invests in Parnell Pharmaceuticals

February 1, 2021

Veterinary

DW Healthcare Partners completed an investment in Parnell Pharmaceuticals Holdings Ltd, a fully integrated animal-health pharmaceutical developer and sterile-injectable manufacturer, and took seats on the company's board. DWHP said the capital and board expansion will support Parnell's growth in the U.S. and expansion of its product portfolio and manufacturing capabilities in animal health.